• News
  • Finance

Zogenix shares rise on delayed FDA drug decision

Shares of San Diego drugmaker Zogenix Inc. (Nasdaq: ZGNX) surged Wednesday, as investors speculated that a delayed decision on the company's lead drug will lead to positive approval in coming weeks.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer
Subscribe Today!